GHAM
TTOO

Gilman Hill Asset Management’s T2 Biosystems, Inc TTOO Stock Holding History

Gilman Hill Asset Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2
Closed -$6K – 225
2021
Q4 		$6K Buy
+2
New +$6.96K ﹤0.01% 219

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gilman Hill Asset Management's TTOO Position: Q1 2022 in Review

Gilman Hill Asset Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2022, closing a stake of 2 shares — an estimated $6K sold.

Gilman Hill Asset Management first reported a position in TTOO in Q4 2021 and held it in 1 quarter. The position peaked at $6K in Q4 2021. 67 funds tracked by Wall St. Rank hold TTOO as of Q1 2022.

  • Gilman Hill Asset Management reported no remaining T2 Biosystems, Inc position as of Q1 2022 after selling out during the quarter.
  • Gilman Hill Asset Management sold 2 T2 Biosystems, Inc shares in Q1 2022, an estimated $6K.
  • Gilman Hill Asset Management first reported a position in T2 Biosystems, Inc in Q4 2021 and held it in 1 quarter.
  • Gilman Hill Asset Management's T2 Biosystems, Inc position peaked at $6K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2022.

Based on Gilman Hill Asset Management's 13F filing for Q1 2022, filed 14 Apr 2022.